CV vs FRBN
Comparison between CapsoVision Inc (CV, Company) and Forbion European Acquisition Corp - Class A (FRBN, Company).
CV is from the Healthcare sector, while FRBN is from the Financial Services sector.
CV vs FRBN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CV vs FRBN - Historical Returns
Returns include dividend reinvestment.
CV vs FRBN - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | CV | FRBN |
|---|---|---|
| 2026 | -36.62% | +0.00% |
| 2025 | +205.43% | N/A |
| 2023 | N/A | +110.02% |
| 2022 | N/A | +4.77% |
CV vs FRBN Drawdown Comparison
The maximum drawdown for CV was -67.82%, occurring on Feb 19, 2026. This drawdown has not yet recovered.
The maximum drawdown for FRBN was -34.01%, occurring on Oct 25, 2023. Recovery took 3 trading sessions.
The current CV drawdown is -54.99%. The current FRBN drawdown is -23.72%.
| Rank | CV | FRBN |
|---|---|---|
| #1 | -67.82% Dec 11, 2025 - Feb 19, 2026 | -34.01% Oct 24, 2023 - Oct 27, 2023 |
| #2 | -27.20% Jul 9, 2025 - Oct 22, 2025 | -23.72% Oct 27, 2023 - Oct 31, 2023 |
| #3 | -9.70% Nov 13, 2025 - Nov 26, 2025 | -10.00% Sep 28, 2023 - Oct 24, 2023 |
| #4 | -7.09% Oct 22, 2025 - Nov 11, 2025 | -1.20% Feb 7, 2022 - May 6, 2022 |
| #5 | -4.77% Jul 3, 2025 - Jul 8, 2025 | -0.85% May 6, 2022 - Jul 5, 2022 |
| #6 | -3.16% Nov 26, 2025 - Dec 3, 2025 | -0.82% Aug 15, 2023 - Sep 26, 2023 |
| #7 | N/A | -0.70% Jul 12, 2022 - Sep 2, 2022 |
| #8 | N/A | -0.52% Mar 10, 2023 - Mar 30, 2023 |
| #9 | N/A | -0.49% Sep 28, 2022 - Oct 26, 2022 |
| #10 | N/A | -0.47% Mar 30, 2023 - May 1, 2023 |
| #11 | N/A | -0.44% Jan 5, 2023 - Jan 26, 2023 |
| #12 | N/A | -0.24% Feb 28, 2023 - Mar 10, 2023 |
| #13 | N/A | -0.19% Feb 23, 2023 - Feb 28, 2023 |
| #14 | N/A | -0.18% Jun 1, 2023 - Jun 5, 2023 |
| #15 | N/A | -0.14% Jan 26, 2023 - Jan 31, 2023 |
Correlation
Correlation between CV and FRBN is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks